Experience and commitment to public health

Research + Clinical Trials

Research Projects

Salus conducts clinical research. Read more about our ongoing studies and collaborations.

  • Cannabinoids are compounds found in cannabis that exhibit varied effects depending on which of the 144 different cannabinoids is isolated in a specific cannabis. Within the past year the FDA approved its first cannabinoid-derived drug. We believe this is just the beginning, and that in the near future, cannabinoid-derived medicine will be very influential in the pharmaceutical space.

  • Sign up to be on our list of participants who are interested in learning more about our mental and physical well-being research:

    Sign up to participate


    BudsInfo Knowledge and Attitudes
    Please participate in our cannabis knowledge and attitudes questionnaire:

    Tell us your experience


    PUBLISHED RESEARCH
    Delta-8, a Cannabis-Derived Tetrahydrocannabinol Isomer
    Evaluating Case Report Data in the Food and Drug Administration Adverse Event Reporting System (FAERS) Database

    Read here

  • Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. There are many types of human coronaviruses, including some that commonly cause mild upper-respiratory tract illnesses. COVID-19 is a new disease, caused by a novel (or new) coronavirus that has not previously been seen in humans.

    We participated in the development of a COVID-19 at home questionnaire. If you have had or are having COVID symptoms please participate in our survey:
    Click here to participate

  • Lupus is a systemic autoimmune disease that occurs when your body’s immune system attacks your own tissues and organs. Inflammation caused by lupus can affect many different body systems — including your joints, skin, kidneys, blood cells, brain, heart and lungs.

    We are looking for individuals with lupus to answer questions regarding treatment and progress. The goal in mind is to use data collected to determine the best way to control the disease.

  • Psoriasis is a skin disorder that causes skin cells to multiply up to 10 times faster than normal. This makes the skin build up into bumpy red patches covered with white scales. They can grow anywhere, but most appear on the scalp, elbows, knees, and lower back.

    We are looking for individuals with psoriasis to answer questions regarding treatment and progress. The goal in mind is to use data collected to determine the best way to control the disease.

  • Join our well-being, yoga and tai-chi community.

    We focus on small classes specially designed for people who are new to these practices, seniors, who need a balance to their righteous training, or who face physical challenges for any reason. We tailor each class to our participants.

    Email PRCtrials.info@gmail.com to learn more.

Participants

Contact us to discuss any of our trials or to see if we have other upcoming studies. You may be eligible for one of our ongoing trials or upcoming studies.

  • You are invited to come in for a screening visit. Bring a family member or friend if you like.

    We will discuss the study and give you plenty of time to ask questions. You will meet some of our study staff. If you want to join in, great! If you decide the study is not for you, you are under no obligation to join.

  • There is never a fee for our services or to see if you qualify. At your request, we can share information and test results we obtain with your other healthcare providers.

  • You will have access to study staff through a dedicated phone line. You will be seen on time, and you will not be rushed. You will get an education about your condition. This will be a different experience compared to your routine health visits.

  • All clinical trials are voluntary. You may choose not to participate or withdraw at any time if you decide to join one of our trials.

Sponsors and Team

Patients deserve access to the latest treatment options and research. Our network of providers and researchers share the PRC+ commitment to the health of the community.

  • Gastroenterology—Neil C. Nagaria, MD
    Ophthalmology—Barinder Athwal, MD
    Pulmonology—Yeshavanth Nayak, MD
    Internal Medicine—Gregory Cartnick, MD; Gregory J. Cuozzo, MD
    Dermatology—Sal La Forgia, MD
    Rheumatology—Rajat Dhar, MD; Phil Molloy, MD
    Health Outcomes—Mark Ganter, MD
    Psychology—Dr. Sam Khorrami, PhD
    Chief Cannabis Advisor—Dr. Jahan Marcu, PhD

  • Meghan Bauer, Moravian College: Behavioral Neuroscience + Chemistry

    Erin Heaning, Princeton University: Psychology + Neuroscience and Gender and Sexuality Studies

    Anthony Silvestrone, Fairfield University: Public Health

  • We have clinical coordinators as part of the PRC+ network. Our main coordinator is Debra Mack. With 10-plus years of experience, her focus is on the patient. Her attention to detail and caring personality make her an excellent clinical coordinator.

  • CLICK HERE to see a list of our sponsors and partners

  • Dr. Henry Simon spent 25 years working with a devoted staff of researchers conducting clinical research studies—his first study was with Connaught Laboratories in 1992 studying the efficacy of a Lyme disease vaccine. His staff, fellow physicians, and a trained clinical coordinators have joined to create a network of physicians and clinical research staff to advance medical research in the local community.

Experience

Our experience and accessibility support our sponsors and participants for successful trials.

  • Experience in Phase 2 to Phase 4 studies, disease and drug registries, and chart review and health outcomes studies.

  • We have standard operating procedures for clinical trials, QA audit tools and procedures for FDA compliance, and quick source documentation development.

  • We are trained in GCP and FDA regulations, in Safety Pak, and in Human Participant Protections Education and Human Subject Assurance.

  • We provide an ongoing review of clinical trials regulations, as well as prompt turnaround of regulatory documents, contracts, and budgets.

    Study have one point of contact, and we provide a subject recruitment plan and execution. Our coordinators are well trained.

    We have a large network of physicians and patients and the ability to use a central IRB.

    All office locations are in central New Jersey. We have a demographically and ethnically diverse patient population and high enrollment in past studies.

  • Our specialities include but are not limited to:

    Cardiology, Dentistry, Dermatology, Endocrinology, Gastroenterology, Infectious diseases, Internal & General Medicine, Nephrology, Obstetrics & Gynecology, Ophthalmology, Orthopedic surgery, Psychology, Pulmonology, Radiology, Rheumatology